These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
368 related items for PubMed ID: 17138135
1. Molecular markers of prostate cancer. Bradford TJ, Tomlins SA, Wang X, Chinnaiyan AM. Urol Oncol; 2006; 24(6):538-51. PubMed ID: 17138135 [Abstract] [Full Text] [Related]
3. New molecular biomarkers for the prognosis and management of prostate cancer--the post PSA era. Bickers B, Aukim-Hastie C. Anticancer Res; 2009 Aug; 29(8):3289-98. PubMed ID: 19661347 [Abstract] [Full Text] [Related]
4. Blood biomarkers for prostate cancer detection and prognosis. Shariat SF, Karam JA, Roehrborn CG. Future Oncol; 2007 Aug; 3(4):449-61. PubMed ID: 17661720 [Abstract] [Full Text] [Related]
5. Biomarkers for prostate cancer detection. Parekh DJ, Ankerst DP, Troyer D, Srivastava S, Thompson IM. J Urol; 2007 Dec; 178(6):2252-9. PubMed ID: 17936845 [Abstract] [Full Text] [Related]
6. New circulating biomarkers for prostate cancer. Bensalah K, Lotan Y, Karam JA, Shariat SF. Prostate Cancer Prostatic Dis; 2008 Dec; 11(2):112-20. PubMed ID: 17998918 [Abstract] [Full Text] [Related]
7. Beyond PSA: utility of novel tumor markers in the setting of elevated PSA. Lin DW. Urol Oncol; 2009 Dec; 27(3):315-21. PubMed ID: 19414121 [Abstract] [Full Text] [Related]
8. Proteomic analysis of conditioned media from the PC3, LNCaP, and 22Rv1 prostate cancer cell lines: discovery and validation of candidate prostate cancer biomarkers. Sardana G, Jung K, Stephan C, Diamandis EP. J Proteome Res; 2008 Aug; 7(8):3329-38. PubMed ID: 18578523 [Abstract] [Full Text] [Related]
10. [Biomarkers for prostate cancer in predicting diagnosis, staging and prognosis]. Ohori M. Gan To Kagaku Ryoho; 2009 Jan 01; 36(1):6-10. PubMed ID: 19151558 [Abstract] [Full Text] [Related]
11. Cancer biomarkers: knowing the present and predicting the future. Chatterjee SK, Zetter BR. Future Oncol; 2005 Feb 01; 1(1):37-50. PubMed ID: 16555974 [Abstract] [Full Text] [Related]
12. Proteomics in prostate cancer biomarker discovery. Larkin SE, Zeidan B, Taylor MG, Bickers B, Al-Ruwaili J, Aukim-Hastie C, Townsend PA. Expert Rev Proteomics; 2010 Feb 01; 7(1):93-102. PubMed ID: 20121479 [Abstract] [Full Text] [Related]
13. [Markers for diagnosis, prediction and prognosis of prostate cancer]. Taskén KA, Angelsen A, Svindland A, Eide T, Berge V, Wahlquist R, Karlsen S. Tidsskr Nor Laegeforen; 2005 Dec 01; 125(23):3279-82. PubMed ID: 16327854 [Abstract] [Full Text] [Related]
14. Biomarkers for prostate cancer detection. Reed AB, Parekh DJ. Expert Rev Anticancer Ther; 2010 Jan 01; 10(1):103-14. PubMed ID: 20014890 [Abstract] [Full Text] [Related]
15. Biomarkers in prostate cancer diagnosis and prognosis: beyond prostate-specific antigen. Fradet Y. Curr Opin Urol; 2009 May 01; 19(3):243-6. PubMed ID: 19325493 [Abstract] [Full Text] [Related]
16. New blood-based biomarkers for the diagnosis, staging and prognosis of prostate cancer. Shariat SF, Karam JA, Margulis V, Karakiewicz PI. BJU Int; 2008 Mar 01; 101(6):675-83. PubMed ID: 17941930 [Abstract] [Full Text] [Related]
17. Medical technologies for the diagnosis of prostate cancer. Fitzsimons NJ, Sun L, Moul JW. Expert Rev Med Devices; 2007 Mar 01; 4(2):227-39. PubMed ID: 17359227 [Abstract] [Full Text] [Related]